REG - Oxford Biomedica PLC - Block Listing Return

Oxford BioMedicaAnnouncement

02/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250102:nRSB8214Ra&default-theme=true

RNS Number : 8214R  Oxford Biomedica PLC  02 January 2025

 For Immediate Release  2 January 2025

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Employee Share Option Scheme
 Period of return:                        From:                                    1 July 2024   To:           31 December 2024
 Balance of unallotted securities under scheme(s) from previous return:            294,719
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         11,197
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        283,522

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 and 2024 Long Term Incentive Plan
 Period of return:                        From:                                    1 July 2024    To:            31 December 2024
 Balance of unallotted securities under scheme(s) from previous return:            393,299
 Plus:  The amount by which the block scheme(s) has been increased since the       600,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         433,280
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        560,019

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 and 2024 Deferred Bonus Plan
 Period of return:                        From:                                    1 July 2024   To:           31 December 2024
 Balance of unallotted securities under scheme(s) from previous return:            286,791
 Plus:  The amount by which the block scheme(s) has been increased since the       300,000
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         211,730
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        375,061

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   Sharesave Scheme
 Period of return:                        From:                                    1 July 2024  To:      31 December 2024
 Balance of unallotted securities under scheme(s) from previous return:            339,753
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         713
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        339,040

 

 Name of contact:              Natalie Walter, Company Secretary
 Telephone number of contact:  01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRUAUNRVSUARAR